{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:10:01Z","timestamp":1791040201563,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.ejphar.2010.09.009","type":"journal-article","created":{"date-parts":[[2010,9,21]],"date-time":"2010-09-21T13:07:44Z","timestamp":1285074464000},"page":"249-254","source":"Crossref","is-referenced-by-count":13,"title":["Glybenclamide: An antidiabetic with in vivo antithrombotic activity"],"prefix":"10.1016","volume":"649","author":[{"given":"Harold J.","family":"Ting","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi T.","family":"Khasawneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2010.09.009_bb0005","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1182\/blood-2008-09-180687","article-title":"Antithrombotic effects of targeting alphaIIbbeta3 signaling in platelets","volume":"113","author":"Ablooglu","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2010.09.009_bb0010","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2125.2007.03058.x","article-title":"Old drugs\u2013new uses","volume":"64","author":"Aronson","year":"2007","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/ecam\/nem010","article-title":"Interaction of aqueous extract of Pleurotus pulmonarius (Fr.) Quel-Champ. with Glyburide in alloxan induced diabetic mice","volume":"5","author":"Badole","year":"2008","journal-title":"Evid. Based Complement Altern. Med."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0020","doi-asserted-by":"crossref","first-page":"49323","DOI":"10.1074\/jbc.M407889200","article-title":"Factor XI interacts with the leucine-rich repeats of glycoprotein Ibalpha on the activated platelet","volume":"279","author":"Baglia","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0025","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/194927b0","article-title":"Aggregation of blood platelets by adenosine diphosphate and its reversal","volume":"194","author":"Born","year":"1962","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2010.09.009_bb0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1026437522882","article-title":"Co-localization of CD9 and GPIIb-IIIa (alpha IIb beta 3 integrin) on activated platelet pseudopods and alpha-granule membranes","volume":"29","author":"Brisson","year":"1997","journal-title":"Histochem. J."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0035","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0049-3848(80)90420-X","article-title":"Thromboxane production and platelet aggregation in diabetic subjects with clinical complications","volume":"19","author":"Butkus","year":"1980","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0040","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/448645a","article-title":"New uses for old drugs","volume":"448","author":"Chong","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2010.09.009_bb0045","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199110173251605","article-title":"Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin","volume":"325","author":"Clarke","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0050","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nrd1610","article-title":"Macro trends in pharmaceutical innovation","volume":"4","author":"Cohen","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0055","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Davi","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0060","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0049-3848(82)90254-7","article-title":"Thromboxane B2 formation and platelet sensitivity to prostacyclin in insulin-dependent and insulin-independent diabetics","volume":"26","author":"Davi","year":"1982","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0065","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.diabet.2009.01.004","article-title":"Effects of exposure of human islet beta-cells to normal and high glucose levels with or without gliclazide or glibenclamide","volume":"35","author":"Del Guerra","year":"2009","journal-title":"Diab. Metab."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0070","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/BF01548050","article-title":"Basic pharmacological research on the hypoglycemic action of N-4-[beta-(2-methoxy-5-chlorbenzamide)-ethyl]-benzosulfonyl-N'-cyclohexylu rea (Glybenclamide)","volume":"6","author":"Dessi","year":"1969","journal-title":"Acta Diabetol. Lat."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0075","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0167-6296(02)00126-1","article-title":"The price of innovation: new estimates of drug development costs","volume":"22","author":"DiMasi","year":"2003","journal-title":"J. Health Econ."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0080","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/MOH.0b013e3280dce51a","article-title":"Signaling and regulation of the platelet glycoprotein Ib-IX-V complex","volume":"14","author":"Du","year":"2007","journal-title":"Curr. Opin. Hematol."},{"issue":"6398","key":"10.1016\/j.ejphar.2010.09.009_bb0085","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/bmj.287.6398.1015","article-title":"Topical minoxidil in the treatment of alopecia areata","volume":"287","author":"Fenton","year":"1983","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"10.1016\/j.ejphar.2010.09.009_bb0090","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0090-6980(84)80006-4","article-title":"Synthesis of [17, 18\u20133H] trans-13-azaprostanoic acid. A labeled probe for the PGH2\/TXA2 receptor","volume":"27","author":"Ghali","year":"1984","journal-title":"Prostaglandins"},{"key":"10.1016\/j.ejphar.2010.09.009_bb0095","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.2337\/diacare.21.7.1138","article-title":"Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971\u20131993","volume":"21","author":"Gu","year":"1998","journal-title":"Diab. Care"},{"key":"10.1016\/j.ejphar.2010.09.009_bb0100","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1146\/annurev.pa.29.040189.001241","article-title":"Thromboxane, prostaglandin and leukotriene receptors","volume":"29","author":"Halushka","year":"1989","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0105","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/349617a0","article-title":"Cloning and expression of cDNA for a human thromboxane A2 receptor","volume":"349","author":"Hirata","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2010.09.009_bb0110","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF01728201","article-title":"Glibenclamide causing thrombocytopenia and bleeding tendency: case reports and a review of the literature","volume":"66","author":"Israeli","year":"1988","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0115","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1021\/ci00020a041","article-title":"A proposed common spatial pharmacophore and the corresponding active conformations of some TxA2 receptor antagonists","volume":"34","author":"Jin","year":"1994","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0120","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0006-2952(92)90294-S","article-title":"Purification of the human blood platelet thromboxane A2\/prostaglandin H2 receptor protein","volume":"43","author":"Kim","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.hoc.2006.11.005","article-title":"Protease activated receptors: clinical relevance to hemostasis and inflammation","volume":"21","author":"Landis","year":"2007","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0130","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1073\/pnas.76.8.4097","article-title":"13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane\/endoperoxide receptor","volume":"76","author":"Le Breton","year":"1979","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2010.09.009_bb0135","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.atherosclerosis.2009.02.034","article-title":"Antithrombotic and antiplatelet activities of fenofibrate, a lipid-lowering drug","volume":"206","author":"Lee","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2010.09.009_bb0140","first-page":"347","article-title":"The effect of octreotide on glucose and insulin levels in a patient with type 2 diabetes on glibenclamide","volume":"25","author":"Lee","year":"1999","journal-title":"Diab. Metab."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0145","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1440-1681.2006.04438.x","article-title":"Role of ATP-sensitive potassium channels in normal and hypertension-associated pregnancy in rats","volume":"33","author":"Lima","year":"2006","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0150","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1476-5381.1989.tb12017.x","article-title":"GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro","volume":"97","author":"Lumley","year":"1989","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0155","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.phrs.2006.06.003","article-title":"Oleanolic acid, a pentacyclic triterpene attenuates capsaicin-induced nociception in mice: possible mechanisms","volume":"54","author":"Maia","year":"2006","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0160","doi-asserted-by":"crossref","first-page":"37430","DOI":"10.1074\/jbc.M506518200","article-title":"Stimulatory roles of nitric-oxide synthase 3 and guanylyl cyclase in platelet activation","volume":"280","author":"Marjanovic","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0165","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1055\/s-0029-1145258","article-title":"Determinants of bleeding risk in patients on antithrombotic and antifibrinolytic drugs","volume":"34","author":"Meijer","year":"2008","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0170","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1073\/pnas.76.6.2566","article-title":"Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation","volume":"76","author":"Nicolaou","year":"1979","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2010.09.009_bb0175","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1056\/NEJM198809223191206","article-title":"Clinical implications of prostaglandin and thromboxane A2 formation (2)","volume":"319","author":"Oates","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0180","first-page":"133","article-title":"Overview of physiological and pathophysiological effects of thromboxane A2","volume":"46","author":"Ogletree","year":"1987","journal-title":"Fed. Proc."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0185","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0022-3565(25)23466-8","article-title":"Pharmacological actions of SQ 29, 548, a novel selective thromboxane antagonist","volume":"234","author":"Ogletree","year":"1985","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0190","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJM199405053301808","article-title":"Aspirin as an antiplatelet drug","volume":"330","author":"Patrono","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0195","first-page":"IV130","article-title":"Thromboxane biosynthesis in cardiovascular diseases","volume":"21","author":"Patrono","year":"1990","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2010.09.009_bb0200","first-page":"S312","article-title":"Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death","volume":"43","author":"Patscheke","year":"1984","journal-title":"Biomed. Biochim. Acta"},{"key":"10.1016\/j.ejphar.2010.09.009_bb0205","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/FJC.0b013e31818eee5f","article-title":"Aspirin resistance: focus on clinical endpoints","volume":"52","author":"Pusch","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"Suppl K","key":"10.1016\/j.ejphar.2010.09.009_bb0210","first-page":"88","article-title":"Cellular activation by thromboxane A2 and other eicosanoids","volume":"14","author":"Reilly","year":"1993","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0753-3322(01)00147-0","article-title":"Management of erythema nodosum leprosum by thalidomide: thalidomide analogues inhibit M. leprae-induced TNFalpha production in vitro","volume":"56","author":"Sampaio","year":"2002","journal-title":"Biomed. Pharmacother."},{"issue":"Suppl 19","key":"10.1016\/j.ejphar.2010.09.009_bb0220","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00535-008-2275-5","article-title":"Prevention of nonsteroidal anti-inflammatory drug-induced gastropathy","volume":"44","author":"Schlansky","year":"2009","journal-title":"J. Gastroenterol."},{"issue":"94\u201397","key":"10.1016\/j.ejphar.2010.09.009_bb0225","first-page":"126","article-title":"A comparison between glibenclamide and glipizide in the treatment of type II diabetes","volume":"30","author":"Shi","year":"1991","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.ejphar.2010.09.009_bb0230","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0014-2999(00)00434-9","article-title":"Z-335, a new thromboxane A(2) receptor antagonist, prevents arterial thrombosis induced by ferric chloride in rats","volume":"401","author":"Tanaka","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0235","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1161\/CIRCULATIONAHA.105.171600","article-title":"Heart disease and stroke statistics\u20142006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"113","author":"Thom","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2010.09.009_bb0240","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1172\/JCI5116","article-title":"Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2","volume":"102","author":"Thomas","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0245","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/aps.2009.195","article-title":"Repurposing an old drug for a new use: glybenclamide exerts antiplatelet activity by interacting with the thromboxane A(2) receptor","volume":"31","author":"Ting","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2010.09.009_bb0255","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1080\/00207450802338721","article-title":"Neuroprotective effects of diazoxide and its antagonism by glibenclamide in pyramidal neurons of rat hippocampus subjected to ischemia-reperfusion-induced injury","volume":"119","author":"Zarch","year":"2009","journal-title":"Int. J. Neurosci."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299910008897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299910008897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T23:40:40Z","timestamp":1740526840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299910008897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":50,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0014299910008897"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2010.09.009","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}